Roche trumps rivals with strongest biotech patent portfolio
Trailing behind the Swiss giant are DowDuPont and Bayer, both of which have seen a drop in the value of their holdings
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.